Found: 118
Select item for more details and to access through your institution.
Genetic Deficiency of Plasma Lipoprotein-Associated Phospholipase A<sub>2</sub> (PLA2G7 V297F Null Mutation) and Risk of Alzheimer's Disease in Japan.
- Published in:
- Journal of Alzheimer's Disease, 2010, v. 21, n. 3, p. 775, doi. 10.3233/JAD-2010-100513
- By:
- Publication type:
- Article
Performance characteristics of plasma amyloid-beta 40 and 42 assays.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Performance Characteristics of Plasma Amyloid-β 40 and 42 Assays.
- Published in:
- Journal of Alzheimer's Disease, 2009, v. 16, n. 2, p. 277, doi. 10.3233/JAD-2009-0948
- By:
- Publication type:
- Article
Predictors of placebo group decline in the Alzheimer's disease Assessment Scale-cognitive subscale (ADAS-Cog) in 24 week clinical trials of Alzheimer's disease.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Alzheimer’s Targeted Treatments: Focus on Amyloid and Inflammation.
- Published in:
- Journal of Neuroscience, 2023, v. 43, n. 47, p. 7894, doi. 10.1523/JNEUROSCI.1576-23.2023
- By:
- Publication type:
- Article
Plasma pTau217 predicts continuous brain amyloid levels in preclinical and early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 8, p. 5617, doi. 10.1002/alz.14073
- By:
- Publication type:
- Article
Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 6, p. 3827, doi. 10.1002/alz.13803
- By:
- Publication type:
- Article
Clinical validation of the PrecivityAD2 blood test: A mass spectrometry‐based test with algorithm combining %p‐tau217 and Aβ42/40 ratio to identify presence of brain amyloid.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 5, p. 3179, doi. 10.1002/alz.13764
- By:
- Publication type:
- Article
Lewy body dementia: Overcoming barriers and identifying solutions.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 3, p. 2298, doi. 10.1002/alz.13674
- By:
- Publication type:
- Article
Predicting clinical progression trajectories of early Alzheimer's disease patients.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 3, p. 1725, doi. 10.1002/alz.13565
- By:
- Publication type:
- Article
Plasma Aβ42/Aβ40 and phospho‐tau217 concentration ratios increase the accuracy of amyloid PET classification in preclinical Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 2, p. 1214, doi. 10.1002/alz.13542
- By:
- Publication type:
- Article
Racial and Ethnic Differences in Plasma Biomarker Eligibility in a Preclinical Alzheimer's Disease Trial.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.083020
- By:
- Publication type:
- Article
Estimating Braak stage from [<sup>18</sup>F]MK6240 PET scans.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.083004
- By:
- Publication type:
- Article
Discordance in amyloid positivity defined by Visual Reads VR and Centiloids CL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082823
- By:
- Publication type:
- Article
Prognostic prediction of the longitudinal cognitive trajectory of amyloid‐positive patients with mild dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.080613
- By:
- Publication type:
- Article
Development of Clinical Trial Simulation Tools for Alzheimer's Disease through the Critical Path for Alzheimer's Disease (CPAD) Consortium.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.074773
- By:
- Publication type:
- Article
Detection of brain Tau deposition across Braak stages using plasma pTau181, MRI, and cognitive function assessments.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080575
- By:
- Publication type:
- Article
Lecanemab: Amyloid Reduction and Evidence of Downstream Biomarker Modification.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080907
- By:
- Publication type:
- Article
Harmonization of tau‐PET in Alzheimer's disease: comparison of methods to derive CenTauR units for [<sup>18</sup>F]RO948, [<sup>18</sup>F]Flortaucipir, and [<sup>18</sup>F]MK‐6240.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.080421
- By:
- Publication type:
- Article
Harmonization of tau‐PET in Alzheimer's disease: comparison of methods to derive CenTauR units for [18F]RO948, [18F]Flortaucipir, and [18F]MK‐6240.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.082006
- By:
- Publication type:
- Article
The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 4, p. 1227, doi. 10.1002/alz.12748
- By:
- Publication type:
- Article
Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 2, p. 696, doi. 10.1002/alz.12737
- By:
- Publication type:
- Article
Strategies for diverse participant recruitment to a preclinical Alzheimer's Disease prevention trial: The AHEAD study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 11, p. 1, doi. 10.1002/alz.068222
- By:
- Publication type:
- Article
Diversity in Phase 2 and Phase 3 Placebo‐Controlled, Double‐Blind, Lecanemab and Elenbecestat Early Alzheimer's Disease Studies.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.069198
- By:
- Publication type:
- Article
Neuropathological autopsy findings in an individual with Alzheimer's disease who received long‐term treatment with lecanemab (BAN2401).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.069220
- By:
- Publication type:
- Article
Lecanemab (BAN2401) Infusion Reactions and Immunogenicity: Results from Randomized Phase 2 Study and an Open‐Label Extension (OLE).
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.066289
- By:
- Publication type:
- Article
Development of Clinical Trial Simulation Tools for Alzheimer's Disease through the Critical Path for Alzheimer's Disease (CPAD) Consortium.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 10, p. 1, doi. 10.1002/alz.059971
- By:
- Publication type:
- Article
Baseline regional Tau distribution predicts fast cognitive decline in subjects with mild cognitive impairment.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.068154
- By:
- Publication type:
- Article
Development and validation of AI‐based tools for brain amyloid‐β detection using MRI.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.068231
- By:
- Publication type:
- Article
Derivation and evaluation of signatures using plasma β‐amyloid and pTau‐181 for brain amyloid‐β detection.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2022, v. 18, n. 5, p. 1, doi. 10.1002/alz.067811
- By:
- Publication type:
- Article
Preliminary assessment of the clinical effects of lecanemab following 18 months of treatment in the open label extension of the phase 2 proof of concept study, BAN2401‐G000‐201, in subjects with early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057780
- By:
- Publication type:
- Article
Plasma Aβ 42:40 ratio tracks with changes in brain amyloid PET SUVr in the core and open label extension of the phase 2 proof of concept study ban2401‐g000‐201 following treatment with lecanemab in subjects with early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057760
- By:
- Publication type:
- Article
Baseline characteristics for CLARITY AD: A phase 3 placebo‐controlled, double‐blind, parallel‐group, 18‐month study evaluating lecanemab (ban2401) in early Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.054331
- By:
- Publication type:
- Article
AHEAD 3‐45 study: Preliminary screening and baseline characteristics from a placebo‐controlled, double‐blind study evaluating lecanemab in participants with preclinical Alzheimer's disease and elevated (A45 trial) and intermediate (A3 trial) amyloid
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.053143
- By:
- Publication type:
- Article
The design of Dominantly Inherited Alzheimer Disease Trial of the anti‐tau antibody, E‐2814, on the DIAN‐TU Tau Next Generation Platform.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.057320
- By:
- Publication type:
- Article
Initial exploration of a brain age score based on validated computerized cognitive assessments in Japanese individuals: Neuropsychology/Multicultural issues in assessment of dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 6, p. 1, doi. 10.1002/alz.045446
- By:
- Publication type:
- Article
Initial exploration of a brain age score based on validated computerized cognitive assessments in Japanese individuals: Neuropsychology/Multicultural issues in assessment of dementia.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.045446
- By:
- Publication type:
- Article
AHEAD 3‐45 study design: A global study to evaluate the efficacy and safety of treatment with BAN2401 for 216 weeks in preclinical Alzheimer's disease with intermediate amyloid (A3 trial) and elevated amyloid (A45 trial): Clinical trial design and implementation
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044511
- By:
- Publication type:
- Article
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 1, p. 131, doi. 10.1016/j.jalz.2019.06.4956
- By:
- Publication type:
- Article
DT‐01‐01: BAN2401 IN EARLY ALZHEIMER'S DISEASE: NEURODEGENERATION BIOMARKER ANALYSIS FROM A RANDOMIZED PHASE 2 STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P1484, doi. 10.1016/j.jalz.2019.08.004
- By:
- Publication type:
- Article
P1‐048: PLASMA NF‐L AS A BIOMARKER FOR NEURODEGENERATION IN MILD AD SUBJECTS IN THE PHASE 2 NAVIGATE‐AD STUDY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2019, v. 15, p. P251, doi. 10.1016/j.jalz.2019.06.073
- By:
- Publication type:
- Article
P4‐388: TRAILBLAZER‐ALZ (NCT03367403): A PHASE 2 DISEASE‐MODIFICATION COMBINATION THERAPY TRIAL TARGETING MULTIPLE MECHANISMS OF ACTION ALONG THE AMYLOID PATHWAY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1622, doi. 10.1016/j.jalz.2018.07.212
- By:
- Publication type:
- Article
O3‐13‐02: LOBAR CLASSIFICATION OF TAU PET IMAGES IN THE EXPEDITION‐3 TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P1055, doi. 10.1016/j.jalz.2018.06.2844
- By:
- Publication type:
- Article
P1‐326: THE USE OF THE DIGITAL CLOCK DRAWING TEST (DCTCLOCK™) IN THE SCREENING PHASE OF CLINICAL TRIALS FOR ALZHEIMER'S DISEASE.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P416, doi. 10.1016/j.jalz.2018.06.333
- By:
- Publication type:
- Article
O1‐09‐01: SIGNIFICANT AND SUSTAINED FLORBETAPIR F18 UPTAKE REDUCTION IN PATIENTS WITH SYMPTOMATIC ALZHEIMER'S DISEASE WITH LY3002813, A β‐AMYLOID PLAQUE‐SPECIFIC ANTIBODY.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P239, doi. 10.1016/j.jalz.2018.06.2378
- By:
- Publication type:
- Article
IC‐P‐216: LOBAR CLASSIFICATION OF TAU PET IMAGES IN THE EXPEDITION‐3 TRIAL.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2018, v. 14, p. P177, doi. 10.1016/j.jalz.2018.06.2283
- By:
- Publication type:
- Article
Sudden unexpected death in epilepsy in lamotrigine randomized-controlled trials.
- Published in:
- Epilepsia (Series 4), 2013, v. 54, n. 1, p. 135, doi. 10.1111/j.1528-1167.2012.03689.x
- By:
- Publication type:
- Article
Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. N.PAG, doi. 10.1186/s13195-020-00703-5
- By:
- Publication type:
- Article
Secondary prevention of Alzheimer's dementia: neuroimaging contributions.
- Published in:
- Alzheimer's Research & Therapy, 2018, v. 10, n. 1, p. N.PAG, doi. 10.1186/s13195-018-0438-z
- By:
- Publication type:
- Article
An exploration of cognitive subgroups in Alzheimer's disease.
- Published in:
- Journal of the International Neuropsychological Society, 2010, v. 16, n. 2, p. 233, doi. 10.1017/S1355617709991160
- By:
- Publication type:
- Article